In CIH-induced HTN rats, administration of AhR antagonist CH223191 (5 mg/kg/day, gavage, daily) for 14 days prevented the increase in systolic blood pressure by 53 ± 12% and diastolic blood pressure by 44 ± 16%. This evidence concerns the gene AHR and hypertensive disorder.